ArticleClinical and translational medicine2024

Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease.

Minji Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.